Status:
COMPLETED
Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Allergan
Conditions:
Bacterial Infections
Eligibility:
All Genders
18+ years
Brief Summary
Ceftazidime-avibactam is used for treatment of invasive Gram-negative bacterial infections among critically ill patients, including those on continuous venovenous hemodiafiltration . However, dosing o...
Detailed Description
Patients who received ceftazidime-avibactam as part of their clinical care were consented. EMR data was collected as well as PK sampling around their dosing to include the following samples immediatel...
Eligibility Criteria
Inclusion
- Adult patients receiving ceftazidime-avibactam as standard care
Exclusion
- Less than 18 years-old
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04358991
Start Date
January 1 2017
End Date
December 31 2019
Last Update
September 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC
Pittsburgh, Pennsylvania, United States, 15213